HRP20040718A2 - Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid - Google Patents

Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Info

Publication number
HRP20040718A2
HRP20040718A2 HRP20040718A HRP20040718A2 HR P20040718 A2 HRP20040718 A2 HR P20040718A2 HR P20040718 A HRP20040718 A HR P20040718A HR P20040718 A2 HRP20040718 A2 HR P20040718A2
Authority
HR
Croatia
Prior art keywords
chlorophenyl
dichloro
composition containing
medicinal composition
dodecanoic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Shin-Ichiro Kobayashi
Niichiro Takano
Hiroyuki Kawashima
Yasuo Shinoda
Toshio Inagi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of HRP20040718A2 publication Critical patent/HRP20040718A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
HRP20040718 2002-01-16 2004-08-06 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid HRP20040718A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002007022 2002-01-16
PCT/JP2003/000251 WO2003059337A1 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Publications (1)

Publication Number Publication Date
HRP20040718A2 true HRP20040718A2 (en) 2004-12-31

Family

ID=19191302

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040718 HRP20040718A2 (en) 2002-01-16 2004-08-06 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Country Status (20)

Country Link
US (1) US20060051410A1 (ru)
EP (1) EP1473033A1 (ru)
JP (1) JPWO2003059337A1 (ru)
KR (1) KR20040090975A (ru)
CN (1) CN1259909C (ru)
AU (1) AU2003201879B2 (ru)
BR (1) BR0307172A (ru)
CA (1) CA2474014A1 (ru)
EA (1) EA007650B1 (ru)
HR (1) HRP20040718A2 (ru)
IL (1) IL162880A0 (ru)
IS (1) IS7340A (ru)
MX (1) MXPA04006977A (ru)
NO (1) NO20043376L (ru)
NZ (1) NZ534471A (ru)
PL (1) PL373035A1 (ru)
TW (1) TWI252755B (ru)
UA (1) UA80270C2 (ru)
WO (1) WO2003059337A1 (ru)
ZA (1) ZA200406453B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004018634D1 (de) * 2003-05-23 2009-02-05 Kowa Co Carbonsäureverbindung und arzneimittel welches diese enthält
JPWO2005117853A1 (ja) * 2004-06-01 2008-04-03 興和株式会社 高脂血症治療剤及び糖尿病治療剤
EP1772149A1 (en) * 2004-07-27 2007-04-11 Kowa Company. Ltd. Drug for prevention or treatment of diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa

Also Published As

Publication number Publication date
NO20043376L (no) 2004-08-13
CN1612730A (zh) 2005-05-04
CN1259909C (zh) 2006-06-21
TW200302079A (en) 2003-08-01
PL373035A1 (en) 2005-08-08
US20060051410A1 (en) 2006-03-09
MXPA04006977A (es) 2005-04-19
UA80270C2 (en) 2007-09-10
EA200400954A1 (ru) 2004-12-30
BR0307172A (pt) 2004-11-03
IL162880A0 (en) 2005-11-20
EA007650B1 (ru) 2006-12-29
WO2003059337A1 (en) 2003-07-24
KR20040090975A (ko) 2004-10-27
CA2474014A1 (en) 2003-07-24
AU2003201879B2 (en) 2007-09-13
AU2003201879A1 (en) 2003-07-30
IS7340A (is) 2004-06-30
TWI252755B (en) 2006-04-11
JPWO2003059337A1 (ja) 2005-05-19
NZ534471A (en) 2005-08-26
ZA200406453B (en) 2006-06-28
EP1473033A1 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
HK1077515A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
HK1183446A1 (en) Stable pharmaceutical composition containing factor viii viii
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
IL153907A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 2-METHYLENE-19-NOR-20(S)-1alpha, 25-DIHYDROXYVITAMIN D3
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
PL372605A1 (en) Preparations containing at least one diformate
HUP0203275A3 (en) 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
TWI347948B (en) Novel 2',5'-oligoadenylic acid compositions
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
HRP20040718A2 (en) Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
IL164326A0 (en) Nucleic acid and corresponding protein entitled 238p1b2 and pharmaceutical compositions containing the same
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
ZA200110500B (en) Pharmaceutical composition.
AU2003284769A1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU2003275360A8 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20061206

Year of fee payment: 5

OBST Application withdrawn